Lyme disease, caused by the spirochete Borrelia burgdorferi, triggers immune dysfunction that can persist long after the initial tick bite and even after antibiotic treatment. The spirochete uses an arsenal of evasion tactics to dodge the immune system, while fragments of the bacterium left behind can fuel inflammation in joints, nerves, and other tissues for months or years. At the same time, the host’s own immune cells can become reprogrammed in ways that sustain damaging inflammation even when the living organism is gone. Understanding why and how this happens is one of the more active and contentious areas in infectious disease research.
How the Spirochete Evades Immune Defenses
One of your body’s first lines of defense against invading bacteria is the complement system, a cascade of proteins in the blood that punch holes in microbial membranes. B. burgdorferi has evolved a clever workaround. The spirochete produces a surface protein called CspA that grabs human factor H, a regulatory protein your body uses to keep complement from attacking its own cells. By coating itself in factor H, the spirochete essentially disguises itself as “self,” blocking the deposition of complement components on its surface and surviving in human serum. When researchers knocked out the gene for CspA in a virulent strain, the mutant bacteria could no longer bind factor H efficiently and became highly sensitive to killing by human serum, with dramatically increased deposition of complement proteins on their surface.1PubMed Central. CspA-mediated binding of human factor H inhibits complement deposition and confers serum resistance in Borrelia burgdorferi
Complement evasion is just one trick. B. burgdorferi also hides in physical refuges throughout the body. The spirochete produces proteins called decorin-binding proteins (DbpA and DbpB) that let it latch onto decorin, a molecule woven into your connective tissue. In mouse studies, the bacteria were better protected in tissues rich in decorin, like joints and skin, compared to tissues with less of it, like the heart and bladder. When researchers bred mice lacking decorin entirely, the protective niche vanished during chronic infection, and the spirochetes became far more vulnerable to the host’s antibody response.2PubMed Central. Protective niche for Borrelia burgdorferi to evade humoral immunity The extracellular matrix, in other words, acts as a kind of armor for the bacteria, sheltering them in collagen-rich tissues where immune cells have a harder time reaching.3PubMed. Hidden in plain sight: Borrelia burgdorferi and the extracellular matrix
Bacterial Debris That Keeps Inflammation Burning
Even after antibiotics kill the living spirochetes, pieces of them can linger. One of the most significant discoveries in recent Lyme research involves B. burgdorferi‘s peptidoglycan, the structural scaffolding of its cell wall. This peptidoglycan turns out to be chemically unusual: the bacterium does not recycle it during normal cell-wall turnover the way most bacteria do. Instead, it sheds peptidoglycan fragments into surrounding tissue as it grows. Researchers detected this material in the synovial fluid of about 94% of Lyme arthritis patients tested, including many who had already completed both oral and intravenous antibiotic courses. These same fluid samples contained proinflammatory cytokines matching those produced when human immune cells were stimulated with the peptidoglycan in the lab. Injecting the peptidoglycan into mice caused acute arthritis.4PubMed Central. Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis
Follow-up research has extended this finding beyond the joints. The peptidoglycan of B. burgdorferi can persist in discrete tissues throughout the body and provoke systemic inflammatory responses consistent with chronic illness, even in the absence of live bacteria.5PubMed Central. The peptidoglycan of Borrelia burgdorferi can persist in discrete tissues and cause systemic responses consistent with chronic illness This matters because it offers a mechanistic explanation for why some patients remain symptomatic after treatment: the immune system keeps reacting to bacterial remnants it cannot clear. The inflammation is real, measurable, and not dependent on the spirochete still being alive.
How the Innate Immune System Gets Activated and Stays Activated
The initial immune reaction to B. burgdorferi depends heavily on Toll-like receptors, pattern-recognition sensors that sit on the surface and inside immune cells. When human monocytes engulf the spirochete, the phagosome (the internal compartment where bacteria are digested) becomes a signaling platform. Two receptors in particular, TLR2 and TLR8, cooperate to produce a distinctive mix of inflammatory and regulatory cytokines. TLR8, acting through the signaling molecule IRF7, is solely responsible for triggering production of interferon-beta, a signal that shapes downstream immune responses and is not produced when immune cells encounter just the spirochete’s surface lipoproteins alone.6PubMed Central. Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-beta Silencing the genes for TLR1 and TLR2 in monocyte-like cells significantly reduced production of TNF-alpha, IL-8, and IL-6 when those cells were exposed to live spirochetes, confirming how central this pathway is to driving the inflammatory cascade.7PubMed Central. Live Borrelia burgdorferi spirochetes elicit inflammatory mediators from human monocytes via the Toll-like receptor signaling pathway
The spirochete also activates mast cells, the immune cells most people associate with allergies. When exposed to live B. burgdorferi, mast cells degranulate (releasing their stored inflammatory chemicals) and secrete TNF-alpha.8PubMed Central. Borrelia burgdorferi spirochetes induce mast cell activation and cytokine release The spirochete’s surface protein OspC, which is heavily expressed during early transmission from the tick, can independently trigger mast cell degranulation, while whole bacteria provoke a broader inflammatory response.9PubMed Central. Interaction of primary mast cells with Borrelia burgdorferi (sensu stricto): role in transmission and dissemination in C57BL/6 mice Mast cell activation helps explain some of the tissue swelling, pain, and local inflammation seen early in Lyme disease, and may contribute to ongoing symptoms in people whose mast cells remain sensitized.
Metabolic Reprogramming of Immune Cells
One of the more recent threads in Lyme research involves how B. burgdorferi rewires the metabolism of immune cells. Normally, immune cells can flexibly switch between different fuel sources depending on whether they need to fight an infection or calm down. Borrelia infection appears to push monocytes and macrophages toward glycolysis, the rapid but inefficient pathway of breaking down glucose, at the expense of other metabolic programs. In infected monocyte-like cells, researchers observed increased expression of the enzyme LDHA (which produces lactate) and TXN (involved in redox signaling), along with reduced extracellular glucose and increased lactate accumulation in culture.10PubMed Central. Glycolytic reprogramming in host response to Borrelia burgdorferi: A gene signature revealed by integrative bioinformatics analysis and machine learning
This glycolytic shift appears to be driven at least partly by HIF-1α, the same master regulator that cells use to respond to low oxygen. Functional genomics work on human primary immune cells confirmed that HIF-1α pathway activation and increased glycolysis-derived lactate occur during the cytokine response to Borrelia, and these changes were also detectable in actual Lyme disease patients.11PubMed. Functional and Genomic Architecture of Borrelia burgdorferi-Induced Cytokine Responses in Humans The practical consequence is that immune cells locked into glycolysis tend to stay in a pro-inflammatory state, pumping out cytokines even when the trigger for the inflammation has been removed. This metabolic reprogramming may be one reason the inflammatory response outlasts the infection itself.
T-Cell Changes and Genetic Susceptibility
The adaptive immune arm, particularly T cells, shows clear abnormalities in people with lingering Lyme-related illness. In patients with post-treatment Lyme disease (PTLD), researchers found significantly fewer circulating CXCR5+ naïve CD4 T cells compared to healthy controls (roughly 5% versus 8%), and these cells were unexpectedly associated with musculoskeletal pain. The patients also had an increased proportion of a specific CD8 T-cell subtype marked by CXCR3. These immune fingerprints were distinct enough that a statistical classifier could identify PTLD patients with moderate accuracy.12Frontiers in Immunology. Aberrant T-cell phenotypes in a cohort of patients with post-treatment Lyme disease
In Lyme arthritis specifically, roughly half of the CD4 T cells in joint fluid are Th1 cells producing interferon-gamma, indicating a strongly polarized inflammatory environment. Regulatory T cells (Tregs), which normally act as brakes on immune responses, are present and functional in these patients but apparently unable to fully restrain the ongoing joint inflammation.13PubMed Central. Treg cell numbers and function in patients with antibiotic-refractory or antibiotic-responsive Lyme arthritis
Your genetic background significantly influences how this plays out. Some of the strongest evidence for genetic risk in Lyme disease involves HLA-DR alleles, the genes that determine which protein fragments your immune cells present to T cells. In a landmark study, about 57% of patients with chronic Lyme arthritis (lasting one to four years) carried the HLA-DR4 marker, compared to only 9% of those whose arthritis resolved quickly. Among patients without DR4, a secondary association appeared with HLA-DR2. Altogether, roughly 89% of chronic arthritis patients carried one or both markers, compared to 27% of those with short-duration arthritis.14PubMed. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles Later work confirmed that these alleles shape how vigorously immune cells respond to specific Borrelia antigens, effectively determining whether the immune reaction resolves or spirals into chronicity.15PubMed Central. HLA-DR alleles determine responsiveness to Borrelia burgdoferi antigens
Neuroinflammation and Brain Involvement
Lyme disease can affect the nervous system, and the inflammation that occurs there follows its own patterns. In a mouse model, B. burgdorferi was shown to colonize the dura mater (the tough membrane surrounding the brain) and trigger a sterile immune response in brain tissue itself, including upregulation of interferon-stimulated genes and antigen presentation pathways in both the cortex and hippocampus, even in areas where the bacteria were not directly present.16PLOS Pathogens. A murine model of Lyme disease demonstrates that Borrelia burgdorferi colonizes the dura mater and induces inflammation in the central nervous system This finding suggests the brain’s immune activation can extend well beyond the site of bacterial colonization.
Microglia, the resident immune cells of the brain, appear to be central players. In brain tissue from Lyme neuroborreliosis, the chemokines CCL2 and CXCL13 were found in microglia along with endothelial cells, macrophages, and T cells, pointing to a coordinated neuroinflammatory program.17PubMed Central. Possible role of glial cells in the onset and progression of Lyme neuroborreliosis In a rat model of neuroborreliosis, microglial activation was identified as a core component of the disease process. Interestingly, supplementation with acetate (a short-chain fatty acid) reduced microglial activation and lowered brain levels of IL-1β, suggesting that metabolic interventions targeting neuroinflammation could eventually have therapeutic relevance.18PubMed Central. Acetate supplementation reduces microglia activation and brain interleukin-1β levels in a rat model of Lyme neuroborreliosis
Small Fiber Neuropathy and Vascular Effects
One of the more underappreciated consequences of Lyme-related inflammation is damage to small nerve fibers. In a study of patients with post-treatment Lyme disease syndrome, all ten participants had at least one abnormal skin biopsy, with nine showing reduced epidermal nerve fiber density, a hallmark of small fiber neuropathy.19PubMed Central. Association of small fiber neuropathy and post treatment Lyme disease syndrome Small fiber neuropathy can produce widespread pain, tingling, numbness, and autonomic symptoms like dizziness and abnormal sweating. Because standard nerve conduction studies test only large fibers, this type of nerve damage is easily missed on routine testing and requires specialized skin biopsy for diagnosis.
The spirochete also directly activates the lining of blood vessels. In lab studies using human umbilical vein endothelial cells, B. burgdorferi upregulated the adhesion molecules E-selectin, VCAM-1, and ICAM-1 in a dose- and time-dependent fashion. E-selectin expression peaked and fell quickly, but VCAM-1 and ICAM-1 remained elevated for at least 24 hours, promoting the recruitment of neutrophils and other immune cells across the vessel wall.20PubMed Central. Borrelia burgdorferi upregulates expression of adhesion molecules on endothelial cells and promotes transendothelial migration of neutrophils in vitro This activation promotes transmigration of specific T-cell subsets, and the anti-inflammatory cytokine IL-10 can inhibit the process, suggesting that people who produce less IL-10 may experience more vascular inflammation.21PubMed Central. Activation of endothelium by Borrelia burgdorferi in vitro enhances transmigration of specific subsets of T lymphocytes This endothelial activation likely contributes to the perivascular damage seen in many Lyme-affected tissues.
Trained Immunity in Joint Cells
One of the more surprising findings in Lyme research involves “trained immunity,” a concept that upends the old idea that only the adaptive immune system (T cells and B cells) can develop memory. It turns out that certain non-immune cells can also remember past encounters with pathogens and respond more aggressively the next time. In mouse models, fibroblast-like synoviocytes (the cells lining joint spaces) that had previously been exposed to B. burgdorferi mounted a heightened inflammatory response upon re-exposure. This trained phenotype correlated with susceptibility to Lyme arthritis. Skin fibroblasts, by contrast, did not show trained immunity, which correlated with the absence of skin symptoms in those same mice. The trained response was also influenced by the cell’s environment and the host’s genetic background.22PubMed Central. Innate Immune Memory to Repeated Borrelia burgdorferi Exposure Correlates with Murine In Vivo Inflammatory Phenotypes If confirmed in humans, trained immunity in joint cells could help explain why Lyme arthritis recurs or persists in some patients: their joint lining itself has been reprogrammed to overreact.
Gut Disruption and Metabolic Signatures
Lyme disease and its treatment can also reshape the gut microbiome. In a study using nonhuman primates, both the Borrelia infection itself and the doxycycline used to treat it led to a loss of gut bacteria that are important for maintaining intestinal integrity and healthy immune tone.23PubMed Central. Borreliosis and doxycycline treatment disrupt gut microbiota and immune responses in nonhuman primates This double hit, infection plus antibiotic treatment, could compound immune dysregulation, since the gut microbiome plays a major role in calibrating systemic inflammation and immune tolerance. Whether gut-focused interventions (probiotics, dietary changes) can meaningfully improve outcomes for Lyme patients has not been rigorously tested, but the biological plausibility is there.
On the diagnostic front, metabolic profiling is beginning to reveal biochemical fingerprints that distinguish patients with post-treatment Lyme disease symptoms from those who recover fully. Differences in glycerophospholipid, bile acid, and acylcarnitine metabolism have been identified, with as few as six to forty metabolites capable of distinguishing the two groups at defined time points. These findings were validated in a second cohort, lending credibility to the idea that PTLD involves measurable metabolic disruption, not simply persistent subjective symptoms.24PubMed Central. Metabolic Response in Patients With Post-treatment Lyme Disease Symptoms/Syndrome Whether these metabolic signatures will eventually translate into clinical tests or treatment targets remains an open question, but they reinforce the picture of Lyme-related chronic illness as a genuine biological state rather than a diagnostic dead end.
When Co-Infections Compound the Problem
Ticks that carry B. burgdorferi frequently carry other pathogens at the same time, and co-infections can amplify immune dysregulation. In a mouse model, animals simultaneously infected with B. burgdorferi and Babesia microti (a parasite that attacks red blood cells and is transmitted by the same ticks) developed significantly more severe arthritis than animals infected with Borrelia alone. The co-infected mice also showed reduced levels of IL-10 and IL-13, two cytokines that normally help dampen inflammation.25The Journal of Infectious Diseases. Increased Arthritis Severity in Mice Coinfected with Borrelia burgdorferi and Babesia microti In practice, this means that a patient carrying both infections may experience worse inflammatory outcomes than either infection would produce on its own, and standard Lyme treatment alone would not address the co-infection. Clinicians in endemic areas increasingly screen for co-infections like Babesia, Anaplasma, and Ehrlichia when patients present with atypically severe or treatment-resistant symptoms.